BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16465517)

  • 1. [The German Network for Evidence-based Medicine -- DNEbM].
    Perleth M; Lühmann D; Antes G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):278-82. PubMed ID: 16465517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a sustainable European Network for Health Technology Assessment. The EUnetHTA project.
    Kristensen FB; Chamova J; Hansen NW
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):283-5. PubMed ID: 16453137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The critical role of research evidence in the framework of health technology assessment].
    Sauerland S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):251-6. PubMed ID: 16477456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of randomised controlled trials in the medical evaluation of routine procedures].
    Lange S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):272-7. PubMed ID: 16465518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of HTA in German health care. Do we need impact objectives?].
    Gerhardus A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):233-40. PubMed ID: 16453136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiological studies in the HTA evaluation process].
    Behrens T; Ahrens W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):264-71. PubMed ID: 16477457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HTA in the decision-making processes of health care institutions. Current state and relevant questions of regulatory health law].
    Francke R; Hart D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):241-50. PubMed ID: 16482461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evidence and Evidence Gaps - an Introduction].
    Dreier G; Löhler J
    Laryngorhinootologie; 2016 Apr; 95 Suppl 1():S6-S12. PubMed ID: 27128405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health economics and HTA].
    Kulp W; Greiner W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):257-63. PubMed ID: 16465516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short history of health technology assessment in Germany.
    Perleth M; Gibis B; Göhlen B
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():112-9. PubMed ID: 19500440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients].
    Gibis B; Rheinberger P
    Z Arztl Fortbild Qualitatssich; 2002 Feb; 96(2):82-90. PubMed ID: 11921610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidence-based medicine teaching activities in the German-speaking area: a survey].
    Weberschock T; Dörr J; Valipour A; Strametz R; Meyer G; Lühmann D; Steurer J; Horvath K; Donner-Banzhoff N; Forster J; Sauder K; Ollenschläger G
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(1):5-12. PubMed ID: 23415337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The curriculum Health Technology Assessment (HTA)].
    Perleth M; Gerhardus A; Lühmann D; Rüther A;
    Z Arztl Fortbild Qualitatssich; 2006; 100(4):297-302. PubMed ID: 16878799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evidence-based medicine--method, critical appraisal and usefulness for professionalized business practice in medical].
    Portwich P
    Gesundheitswesen; 2005 May; 67(5):319-24. PubMed ID: 15918119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HTA goes Europe: European collaboration on joint assessment and methodological issues becomes reality].
    Nachtnebel A; Mayer J; Erdös J; Lampe K; Kleijnen S; Schnell-Inderst P; Wild C
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):291-9. PubMed ID: 26354129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [EbM from the bottom up: are questions asking for evidence in daily clinical practice answerable?---a report from a pilot test to assist general practitioners with using evidence-based medicine].
    Blank W; Weingart O
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(7):425-30. PubMed ID: 19839529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Innovation in health care: the role of HTA in the introduction of new technologies].
    Bührlen B
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):703-8. PubMed ID: 21147431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.